Ergomed plc Directors' Dealing (0779L)
April 16 2018 - 9:55AM
UK Regulatory
TIDMERGO
RNS Number : 0779L
Ergomed plc
16 April 2018
Ergomed Plc
("Ergomed" or the "Company")
Directors' Dealing
Ergomed, a profitable UK-based group dedicated to the provision
of specialised services to the pharmaceutical industry and the
development of new drugs, announces that on 16 April 2018, Dr
Miroslav Reljanovic, founder and Executive Vice-Chairman of the
Company, sold 4,000,000 ordinary shares of 1p each in the Company
("Share(s)") at a price of 190p per Share to meet institutional
demand.
Following this transaction, Dr Miroslav Reljanovic's holding has
reduced to 11,132,237 shares (representing 24.9 per cent. of the
Company's issued share capital).
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Dr Miroslav Reljanovic
---------------------------------------- --------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------
a) Position/status Founder and Executive Vice-Chairman
---------------------------------------- --------------------------------------
b) Initial notification Initial Notification
/Amendment
---------------------------------------- --------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------
a) Name Ergomed Plc
---------------------------------------- --------------------------------------
b) Legal Entity 213800BVS8I9VMC1AP84
Identifier
---------------------------------------- --------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------
a) Description of Ordinary shares of 1 pence each
the financial
instrument, type
of instrument GB00BN7ZCY67
Identification
code
---------------------------------------- --------------------------------------
b) Nature of the Sale of shares
transaction
---------------------------------------- --------------------------------------
c) Currency GBP
---------------------------------------- --------------------------------------
d) Price(s) and Price(s) Volume(s)
volume(s)
---------------------------------------- ----------------- -------------------
190p 4,000,000
--------------------------------------------- ----------------- -------------------
e) Aggregated information Volume: 4,000,000
- Aggregated Price: 190p
volume Aggregated volume: GBP7,600,000
- Price
- Aggregated
total
---------------------------------------- --------------------------------------
f) Date of the transaction 16 April 2018
---------------------------------------- --------------------------------------
g) Place of the London Stock Exchange, AIM
transaction
---------------------------------------- --------------------------------------
Enquiries:
Ergomed plc Tel: +44 (0) 1483
503205
Stephen Stamp (Chief Executive Officer)
Numis Securities Limited Tel: +44 (0) 20 7260
1000
Michael Meade / Freddie Barnfield (Nominated
Adviser)
James Black (Joint Broker)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHIFMITMBABBJP
(END) Dow Jones Newswires
April 16, 2018 10:55 ET (14:55 GMT)
Ergomed (LSE:ERGO)
Historical Stock Chart
From Apr 2024 to May 2024
Ergomed (LSE:ERGO)
Historical Stock Chart
From May 2023 to May 2024